Medpace Holdings, Inc. (MEDP) Institutional Ownership & Insider Trading

696 institutions reported holding Medpace Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 58 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

MEDPMedpace Holdings, Inc.Follow MEDP — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 18.7B
P/E TTM: 37.2
Dividend yield: —
52-week: —
Next earnings: 8 Feb, in 107 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

696 institutions held 88.3% of the shares. Across filers that reported both quarters, shares held changed +1.7%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	696	25	+1.7%	187	52	276	85
Mar 26	724	24	+2.7%	209	65	269	115
Dec 25	769	24	-1.8%	227	118	237	37
Sep 25	656	24	-8.1%	162	110	250	50
Jun 25	591	26	+3.2%	201	56	209	45
Mar 25	568	25	+0.2%	205	52	183	55
Dec 24	573	25	-0.6%	192	57	187	71
Sep 24	571	25	-0.7%	225	53	173	92

Medpace Holdings, Inc. — questions

Who owns Medpace Holdings, Inc. stock?: 696 institutions reported Medpace Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.9%), PRICE T ROWE ASSOCIATES INC /MD/ (7.4%), AQR CAPITAL MANAGEMENT LLC (4.6%).
Are Medpace Holdings, Inc. insiders buying or selling?: 58 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Medpace Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.